Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02093403
Title Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ramiro Garzon
Indications

acute myeloid leukemia

Therapies

Decitabine + Selinexor

Age Groups: adult
Covered Countries USA


No variant requirements are available.